Browse 1,662 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA
Sponsor: Biostar Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05681000
Phase 1, Recruiting
LIFE Cancer Survivorship Database for Pediatric Cancer
for
Pediatric Cancer
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 0+
Code: NCT01518400
Recruiting
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Fairfax VA, Toronto, Pittsburgh PA, Huntersville NC,
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: New Haven CT, New York NY, Montreal, Wynnewood PA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06581432
Phase 2, Recruiting
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Get alerts for new trials in your area by subscribing now
Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood
for
Pediatric Cancer
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: All
Age: 0 - 21
Code: NCT02242552
Recruiting
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
for
Metastatic Malignant Solid Neoplasm, Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05371132
Phase 1, Recruiting
UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus.